AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04626349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: iFOCUS (web-based intervention)
Description: Self-managed psycho-educational intervention that is completed autonomously by the patient-caregiver dyads together. It encompasses four sessions (with three weeks between each session) over a period of 12 weeks.~The sessions are completed simultaneously by the patient and the family caregiver, sitting side by side at a computer. Patient-caregiver dyads have flexibility as to when they want to complete the intervention session. Based on the information patients and caregivers provided at enrollment and during the web-based sessions, they receive tailored individual and dyadic messages. An online personal workbook is provided containing the results of the interactive exercises that are provided to the dyads during the web-sessions. Any information brochures, leaflets and information sheets that the dyad indicated as 'of interest to them' during the web-sessions will be included as a hyperlink in their personal workbook.
Study NCT06517264 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic
Description: antibiotic treatment, analgesics and hygienic-dietetic measures
Study NCT06517264 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Non antibiotic
Description: Analgesics and hygienic-dietetic measures
Study NCT05677607 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic resonance imaging
Description: Imaging diagnostics mainly based on Magnetic resonance imaging.
Study NCT05445947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The EASEL (Enhancing And Supporting Early Development to Better Children's Lives) Approach
Description: The EASEL Approach consists of a set of educator-led practices that can be incorporated into the daily classroom environment for children three to six years of age. The overall purpose of this approach is to enhance early childhood educators' teaching practices that would promote children's SEB+EF development.~Nine EASEL practices were selected for inclusion in the EASEL Approach. These are a) core fundamental practices that are evidence-based, b) practices that expert stakeholders identified as ones for which local early childhood educators may need additional training, c) practices that are not already covered in pre-service training to avoid replication for educators, d) a combination of practices that educators may already be implementing and can enhance, and new practices, and e) a balance of antecedent and consequential practices (i.e., practices that can be implemented before and after a target behavior).
Study NCT05367700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10382(Part 1: Dose escalation)
Description: Single or multiple dose(s) of HS-10382 once daily.
Study NCT05367700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10382(Part 2: Dose expansion)
Description: HS-10382 is administered orally once daily.
Study NCT04741594 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Densah
Description: Alveolar bone remodeling after tooth extraction may result in significant ridge resorption and inadequate bone volume for implant placement. Several methods have been designed for ridge augmentation, among which is the new technique of osseodensification, using the Densah® burs by Versah® (Versah®, LLC, Jackson, MI, USA). This method compresses the trabecular bone to periphery of the osteotomy site and has shown up to 80% ridge expansion in animal histological studies , , , , , . Apart from being an animal model with a short follow-up, another limitation of these studies is the lack of three-dimensional evaluation of the change in morphology of the ridge. Human clinical studies , , , , have reported similar results, but they do not evaluate if this bone volume is retained during osseointegration and loading periods. No standardization method or long-term evaluation of peri-implant health was reported.
Study NCT04837339 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Collection of biological samples
Description: Blood sample, biopsies sample, hair sample.
Study NCT05663905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ambroxol Hydrochloride
Description: IV ambroxol hydrochloride 30mg TDS as adjunct therapy to standard therapy for severe pneumonia in ICU for 14 days. Each dose of 30mg of ambroxol will be diluted in 50ml of NS/D5% to be given intravenously over an hour.
Study NCT05663905 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Therapy
Description: Standard therapy for severe pneumonia as per recommended in the ICU Management Protocols by Malaysian Society of Intensive Care (MSIC). This includes antibiotics stewardship and supportive therapy.
Study NCT05663905 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Therapy
Description: Standard therapy for severe pneumonia as per recommended in the ICU Management Protocols by Malaysian Society of Intensive Care (MSIC). This includes antibiotics stewardship and supportive therapy.
Study NCT06186869 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Exercise and diet intervention
Description: subjects randomized and assigned to one intervention group, will follow the low glycaemic index Mediterranean diet and simultaneously perform moderate-intensity aerobic exercises
Study NCT06186869 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hiit and diet intervention
Description: subjects randomised and assigned to one intervention group, will follow the low glycaemic index Mediterranean diet and simultaneously perform high-intensity interval exercises in the gym
Study NCT06186869 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet
Description: subjects randomised and assigned to this intervention group will follow the low-glycaemic index Mediterranean diet
Study NCT06415604 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: The content of psychoeducation is based on Five Ways of Well-being which covers Be active, Connect, Take Notice, Keep learning and Giving.
Study NCT06415604 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Attention control
Description: The content of the sessions mainly focuses on physical health information, such as healthy eating, physical exercise, prevention of falls, and pain management.
Study NCT06292442 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional physical therapy
Description: This group received conventional physical therapy treatment including Range of Motion (ROM) exercises for the affected hip, knee, and ankle joints, as well as stretching exercises for tight lower limb muscles, administered 3 times per week for 4 weeks, with each session lasting approximately 20-30 minutes.
Study NCT06292442 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval training
Description: This group received High Intensity interval training along with conventional treatment for lower limb muscles, performed 3 times per week fr 4 weeks.
Study NCT05109208 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ulrasound Vibroelastography (UVE)
Description: Ultrasound technique to quantitatively assess tissue stiffness (elasticity and viscosity) by applying vibration through a specialized probe (indenter).
Study NCT05365399 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: smartphone-based screening tool for neonatal jaundice
Description: In this study we aim to collect data of newborns with wider range of bilirubin levels and high melanin content, and additionally measurements of skin color reflectance with a spectrophotometer, to adjust the Picterus JP algorithm and optimize the app performance. This will enable a high qualitative estimation of bilirubin levels in the blood of new-borns for all skin colors. .
Study NCT05794477 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Specified dose on specified days
Study NCT05794477 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1802
Description: Specified dose on specified days
Study NCT05538936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baby SPA
Description: Salus Per Aquam, Sanitas Per Aquam, Salut Per Aqua or Solus Per Aqua (SPA) means health that comes with water. Baby SPA is a physiotherapy method that stimulates the baby's motor movements through water (hydrotherapy) and performs it in an integrated way to balance the body, mind, and emotions. Baby SPA is applied in specially designed bathtubs. The size of the tub is designed in such a way that children can move their hands and feet freely and not be narrow. A neck ring/ring is used to keep the baby on the water surface during SPA treatment.
Study NCT05538936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: The best way to communicate with a baby is to touch it. When babies are born, unlike their other senses, the most developed one is the sense of touch. Because this process begins while in the womb. The baby communicates by touch and begins to recognize his environment. The sense of touch is a priority for the development of all senses. They need to perceive their environment, especially in newborns and infancy periods. Touching the body in a systematic way for a therapeutic purpose is called Massage. Massage is soft touches to body tissues to relax muscles, accelerate circulation, reduce infantile colic symptoms and pain, regulate sleep, and increase its duration. Baby massage has many benefits such as reducing colic symptoms, increasing weight gain, providing motor development and coordination, strengthening the parent and baby bond, supporting growth and development, and reducing stress.
Study NCT05794477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin/Cisplatin
Description: Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Study NCT05794477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel/Nab-Paclitaxel/Pemetrexed
Description: Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Study NCT05789225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fall prevention program
Description: The intervention consists of the fall prevention program for ambulatory and non-ambulatory people with multiple sclerosis. The program is group-based with 8 participants in each group, led by a facilitator, and performed online. It comprises seven two-hour sessions held once a week, and a booster session held four weeks after the seventh session. In addition participants will receive a brochure about falls and fall risk factors.
Study NCT05789225 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Brochure
Description: Control-group participants will receive a brochure about fall risk factors and fall prevention in addition to the standard MS care and rehabilitation.
Study NCT05845541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology Supported Meditation and Biofeedback
Description: Patient's in the treatment arm will participate in technology based meditation using the iom2 and Journeys app at least 3 times/ week. This will involve placing a probe on their ear attached to the iom2 and following the guidance provided by the Journeys App.~During and following each session, participants will be shown their average heart rate variability (HRV) score, average HRV, and time spent on the session. Patients will be able to review sessions and keep track of their progress. Participants in the intervention arm will be asked to complete the outcome measures prior to their hospital discharge. As well, an informal discussion about the patient's experience using technology based meditation will be transcribed.
Study NCT05845541 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Treatment
Description: Patients at St. John's Rehab undergoing rehabilitation are supported by an interprofessional team - including physiatrists, nurses, occupational therapists, speech language pathologists, physical therapists, social workers and psychiatrists. During their inpatient stay, patients receive a wide range of rehabilitation services aimed at addressing their physical, emotional and cognitive care needs. Length of stay for inpatient services ranges between 2 to 12 weeks.
Study NCT05061381 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A Lust for Life Schools Programme
Description: A Lust for Life is a universal school-based multi-component programme whose target is to build well-being and emotional resilience in children. The programme was informed by evidence-based psychological approaches including mindfulness, cognitive behaviour therapy and positive psychology. It is delivered in six weekly lessons by the childrens' school teacher and involves classroom discussions, videos, classroom activities and homework assignments.
Study NCT05011578 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiographic assessment
Description: Radiographic assessment after at least 10 years after radiocapitellar surgical treatment
Study NCT05650970 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: routine therapy
Description: Routine treatment program including massage, ice and activity training applied to hand thumb osteoarthritis patients
Study NCT05650970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: radial nerve mobilization exercise
Description: Radial nerve mobilization exercise in addition to the routine treatment program applied to patients with hand thumb osteoarthritis
Study NCT04993469 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Semmes-Weinstein monofilament testing and questionnaires
Description: Semmes-Weinstein test for the assessment of genital sensation Battery of questionnaires assessing sexual function, voiding function, quality of life and patient satisfaction
Study NCT05918276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib and BG
Description: Drug: Orelabrutinib Orelabrutinib 200mg, po, qd，C2-C7. Twenty-eight days for a cycle.~Drug: BG Bendamustin 70mg/m2, IV, d2\&d3 inC1, and then d1\&d2 inC2-6.Twenty-eight days for a cycle.~Obintuzumab 100mg IV, d1, 900mg d2, 1000mg d8\&d15 in C1, and then 1000mg/m2 IV, d1 in C2-6. Twenty-eight days for a cycle.
Study NCT05251675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physician Led Professional Coaching
Description: This is a one-on-one intervention between a physician coach and an individual physician. This is meant to help coaches attain valued professional or personal development.
Study NCT05251675 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Delayed Physician Led Professional Coaching
Description: This intervention will include professional one-on-one professional coaching delayed from the active comparator group.
Study NCT06051110 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Combined risk score
Description: Prehospital risk stratification by the use of a combined clinical risk score including POC-troponin
Study NCT06051110 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Prehospital risk stratification by EMS protocols
Study NCT06051110 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: point-of-care troponin
Description: Prehospital risk stratification by the use of a POC-troponin
Study NCT05089747 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling for biomarker analysis (microRNA, circulating DNA…)
Description: From one to four blood samplings: at diagnosis, after the first cycle of treatment, end of treatment, progressive disease (or end of study).
Study NCT05157945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALTO-300 PO Tablet
Description: One tablet daily
Study NCT05459155 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Synapse medicine platform
Description: Intervention is the Synapse medicine platform for inpatient pharmacists. This software analyzes drug-related risks based on each patient's clinical characteristics
Study NCT06330935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic Acid (TXA)
Description: 30 patients will be randomized to A arm and 30 patients to B arm
Study NCT06330935 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: 30 patients will be randomized this arm C
Study NCT05163223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AST-301(pNGVL3-hICD)
Description: Q3W, 3 cycles, Plus a booster at 24 weeks post the third vaccination, Intradermal injection
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhuGM-CSF
Description: Q3W, 3 cycles, Plus a booster at 24weeks post the third vaccination, Intradermal injection
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rhuGM-CSF
Description: Q3W, 3 cycles, Plus a booster at 24weeks post the third vaccination, Intradermal injection
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Q3W, 3 cycles, Plus a booster at 24 weeks post the third vaccination, Intradermal injection
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Q3W; IV infusion
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Q3W; IV infusion
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: On days 1-14 (Q3W), BID ; Oral administration,
Study NCT04390308 — intervention group
Intervention type: PROCEDURE
Intervention: Ovarian puncture
Description: Egg collection
Study NCT04390308 — intervention group
Intervention type: OTHER
Intervention: Hormonal blood Test
Description: AMH (ng/ml), FSH (IU/mL), E2(pg/mL), P4(ng/mL), LH (IU/mL)
Study NCT04390308 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transvaginal ultrasound
Description: Doppler of arteria ovarica. Resistance index
Study NCT05963932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986419 DR Capsule
Description: Specified dose on specified days
Study NCT05963932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986419 IR Tablet
Description: Specified dose on specified days
Study NCT05765669 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous screw fixation
Description: Surgical intervention in the form of percutaneous screw fixation
Study NCT05765669 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain management
Description: Non-operative management in the form of pain management and physical therapy advanced with weightbearing as tolerated
Study NCT05765669 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy
Description: Non-operative management in the form of pain management and physical therapy advanced with weightbearing as tolerated
Study NCT05312970 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varithena®
Description: Varithena® (polidocanol injectable foam) 1%
Study NCT05312970 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FDA-approved Endothermal Ablation (ETA) systems
Description: FDA-approved ETA systems, including Radiofrequency ablation (RFA) systems or Endovenous laser ablation (EVLA) systems.
Study NCT05284903 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Beamformer Benefit: Speech intelligibility and Listening effort
Description: Confirm the improvement in terms of speech intelligibility (measured by OLSA, Oldenburg Sentence Test) and the reduction in terms of listening effort (measured by ACALES) of the I-BF (investigational Beamformer) compared to the R-BF (reference Beamformer), when speech is not coming from the front.
Study NCT05284903 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Speech Enhancer benefit: Speech intelligibility, Listening effort and Subjective Speech intelligibility
Description: Confirm the improvement in terms of speech intelligibility (measured by Oldenburg Sentence test) and the reduction in terms of listening effort (measured by ACALES) when the Speech Enhancer is on (SE ON) compared to Speech Enhancer is off (SE OFF) for distant speech or speech from adjacent room.~Confirm the improvement in terms of subjective level to follow a conversation in quiet when SE ON compared to SE OFF for distant speech or speech from adjacent room. Measured by a subjective assessment.
Study NCT05284903 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hearing aid benefit: Speech intelligibility in noise (unaided vs aided condition)
Description: Confirm the improvement in terms of speech intelligibility (measured by OLSA) in noise with the investigational device (aided condition) compared to the unaided condition.
Study NCT05163223 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: On days 1-14 (Q3W), BID ; Oral administration,
Study NCT04921618 — intervention group
Intervention type: OTHER
Intervention: 2 online self-administered questionnaires on
Description: 1. Participant profile~2. Spontaneous partner notification practices collected one month after STIs diagnosis
Study NCT04921618 — intervention group
Intervention type: OTHER
Intervention: 2 online self-administered questionnaires on
Description: 1. Participant profile~2. Experiences with partner notification and use of STI testing following notification
Study NCT06381167 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Decompressive Laminectomy
Description: the patients will undergo block randomization for either endoscopic or microscopic decompression
Study NCT05284903 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hearing aid benefit: Speech intelligibility in noise (aided condition)
Description: Confirm the improvement in terms of speech intelligibility (measured by OLSA) with the Reference binaural beamformer compared to the fixed directional.
Study NCT04946526 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Broccoli seed extract
Description: 2 capsules, one dose